Skip to main content
Home
Search Help
  • Topics
  • Directory
  • Resources
    • Research Tools
    • ELSI Publications
    • ELSIhub Collections
    • ELSI Congresses
    • Resources for Educators
    • SNAPSHOTs
    • Additional Resources
    • Videos
    • Jobs
  • Funding
    • Funding Opportunities
    • ELSI Grant Abstracts
    • Training Videos
    • Additional Funding Resources
    • Funding FAQs
  • News & Events
    • ELSI Friday Forum
    • ELSIconversations
    • ELSI Journal Club
    • ELSIHub News
    • Events
    • TraineeHub
    • In the Media
    • Videos
    • Newsletter
    • Jobs
  • About
    • Welcome
    • CERA FAQs
    • What is ELSI Research?
    • Leadership & Organization
    • CERA Working Groups
    • Accessibility and Usability
    • Contact Us
  • Contribute Content
Twitter Vimeo LinkedIn ELSIhub calendar of events Subscribe to our newsletter Instagram
+ Add Listing
  • + Login
  • + Register
Search Help
Document Type
Study FAQ

CSER Phase 1: MIONCOSEQ Study FAQs

Author(s):

Author Name(s)
University of Michigan

This document provides answers to frequently asked questions for participants in Personalized Oncology Through High-throughput Sequencing: Michigan Oncology Sequencing Center (MI-ONCOSEQ) Study.

Research Population:

Research Population
Adults

Return to Search Results

Share

Source
View online source

Newsletter

Sign up to receive the latest updates from ELSIhub.

Home
  • Privacy Policy
  • Terms of Use
  • Accessibility
Main contact:
[email protected]
Media contact:
[email protected]
Follow Us:
VimeoTwitter

ELSIhub is financially supported by the National Human Genome Research Institute at the National Institutes of Health (U24HG010733). It is managed at Stanford and Columbia Universities in partnership with the Hastings Center and Case Western Reserve University.

Tell us anything